The companies will partner on two clinical studies in dementia that combines Wavi's electroencephalogram-based biomarkers and SomaLogic's blood-based protein biomarkers.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.